The effect of dexmedetomidine on the changes induced by midazolam in proliferation, differentiation and apoptosis of neural stem cells in vitro

雷珊,张蓬勃,李慧娴,张红,李蓉,李卫松,郑娟,吕海侠,陈新林
DOI: https://doi.org/10.3760/cma.j.issn.1673-4378.2016.03.006
2016-01-01
Abstract:Objective To investigate the effects of dexmedetomidine (Dex) on the proliferation,differentiation and apoptosis of neural stem cells (NSCs) of rats induced by midazolam in vitro.Methods NSCs were isolated from the cerebral cortex of rat embryos on embryonic day 14-15,and P1-P2 cells were treated with midazolam,Dex combined with midazolam 24 h,with the untreated cells served as control.Cell viability was detected by MTT assay.Cell proliferation was evaluated by 5-bromo-2-deoxyuridine (BrdU) incorporation.Immunocytochemical staining was used to study the differentiation of NSCs.Cell apoptosis was assessed by TUNEL.Results Treatment with midazolam significantly inhibited cell viability [C group (0.214±0.006),M group (0.187±0.002)] and proliferation[C group(35.7±1.0)%,Mid group (27.6%±1.0%)],increased the cell apoptosis[C group (5.7±0.8)%,Mid group(7.8±1.1)%](P<0.01),but did not affect the differentiation of NSCs(P>0.05).Compared with M group,the combination of Dex and midazolam significantly improved cell viability(0.233±0.007) and proliferation(35.7±1.1)%,and decreased the cell apoptosis(5.3±1.0)% (P<0.01).There was no significant difference in the differentiation of NSCs between the M group and the M+D group (P>0.05).Conclusions Treatment with Dex improves the decreased NSCs proliferation and increased cell apoptosis induced by midazolam,but has no significant influence on differentiation of NSCs into neurons and astrocytes.
What problem does this paper attempt to address?